TNXP 8-K 2026-08-10

Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K dated 2026-08-10 — accession 0001493152-26-036740. This URL is the filing, not the TNXP hub.

Tonix Pharmaceuticals Holding Corp. (TNXP) is a biotechnology company listed on NASDAQ.

Tonix Pharmaceuticals Holding Corp. filed a 8-K on 2026-08-10. Accession 0001493152-26-036740.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.

Not investment advice. The TNXP SEC hub lists recent forms. The stock page is the research view.